ATE466025T1 - Physiologisch aktive peptide und medikamente, die diese enthalten - Google Patents

Physiologisch aktive peptide und medikamente, die diese enthalten

Info

Publication number
ATE466025T1
ATE466025T1 AT04713248T AT04713248T ATE466025T1 AT E466025 T1 ATE466025 T1 AT E466025T1 AT 04713248 T AT04713248 T AT 04713248T AT 04713248 T AT04713248 T AT 04713248T AT E466025 T1 ATE466025 T1 AT E466025T1
Authority
AT
Austria
Prior art keywords
physiologically active
seq
peptide
amino acid
active peptides
Prior art date
Application number
AT04713248T
Other languages
English (en)
Inventor
Takashi Takata
Shoji Kitagawa
Yuji Kaneda
Original Assignee
Seikagaku Kogyo Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Seikagaku Kogyo Co Ltd filed Critical Seikagaku Kogyo Co Ltd
Application granted granted Critical
Publication of ATE466025T1 publication Critical patent/ATE466025T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728—Hyaluronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Medical Uses (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicinal Preparation (AREA)
AT04713248T 2003-02-21 2004-02-20 Physiologisch aktive peptide und medikamente, die diese enthalten ATE466025T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2003045166 2003-02-21
JP2003142845A JP2004307454A (ja) 2003-02-21 2003-05-21 生理活性ペプチド及びこれを含有する薬剤
PCT/JP2004/002009 WO2004074319A1 (ja) 2003-02-21 2004-02-20 生理活性ペプチド及びこれを含有する薬剤

Publications (1)

Publication Number Publication Date
ATE466025T1 true ATE466025T1 (de) 2010-05-15

Family

ID=32911432

Family Applications (2)

Application Number Title Priority Date Filing Date
AT04713248T ATE466025T1 (de) 2003-02-21 2004-02-20 Physiologisch aktive peptide und medikamente, die diese enthalten
AT08006914T ATE529440T1 (de) 2003-02-21 2004-02-20 Biologisch aktives peptid und wirkstoff, der dieses enthält

Family Applications After (1)

Application Number Title Priority Date Filing Date
AT08006914T ATE529440T1 (de) 2003-02-21 2004-02-20 Biologisch aktives peptid und wirkstoff, der dieses enthält

Country Status (7)

Country Link
US (2) US7365153B2 (de)
EP (2) EP2000478B1 (de)
JP (3) JP2004307454A (de)
AT (2) ATE466025T1 (de)
DE (1) DE602004026840D1 (de)
ES (2) ES2347245T3 (de)
WO (1) WO2004074319A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004307454A (ja) * 2003-02-21 2004-11-04 Seikagaku Kogyo Co Ltd 生理活性ペプチド及びこれを含有する薬剤
US8707326B2 (en) * 2012-07-17 2014-04-22 Concurix Corporation Pattern matching process scheduler in message passing environment
US9575813B2 (en) 2012-07-17 2017-02-21 Microsoft Technology Licensing, Llc Pattern matching process scheduler with upstream optimization
CN119241640B (zh) * 2024-12-06 2025-04-25 杭州康源食品科技有限公司 一种促进骨骼生长的三肽

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL324518A1 (en) 1995-07-13 1998-06-08 Biora Ab Polypeptide showing affinity to enamel matrix
US6300062B1 (en) * 1995-07-13 2001-10-09 Biora Ab Enamel matrix related polypeptide
US20010039335A1 (en) * 1997-04-10 2001-11-08 Kenneth Jacobs Secreted proteins and polynucleotides encoding them
CA2316973A1 (en) 1998-01-07 1999-07-15 Genetics Institute, Inc. Secreted proteins and polynucleotides encoding them
JP4726296B2 (ja) * 1998-02-27 2011-07-20 インスティチュート ストローマン アーゲー 創傷治癒のためのマトリックスタンパク質組成物
ES2183510T3 (es) 1998-02-27 2003-03-16 Biora Bioex Ab Composiciones de proteinas de matriz para la cicatrizacion de heridas.
ATE258442T1 (de) * 1999-03-10 2004-02-15 Biora Bioex Ab Matrixprotein zusammensetzungen für pfropfung in nicht mineralisierten geweben
CN1302883A (zh) * 1999-10-29 2001-07-11 上海博道基因技术有限公司 一种新的多肽——人成釉质蛋白23和编码这种多肽的多核苷酸
JP2004307454A (ja) * 2003-02-21 2004-11-04 Seikagaku Kogyo Co Ltd 生理活性ペプチド及びこれを含有する薬剤

Also Published As

Publication number Publication date
US20090137482A1 (en) 2009-05-28
US7365153B2 (en) 2008-04-29
JPWO2004074319A1 (ja) 2006-06-01
EP1602665A1 (de) 2005-12-07
EP1602665A4 (de) 2007-07-18
JP4630816B2 (ja) 2011-02-09
JP5047323B2 (ja) 2012-10-10
ES2347245T3 (es) 2010-10-27
DE602004026840D1 (de) 2010-06-10
EP2000478A1 (de) 2008-12-10
ES2378711T3 (es) 2012-04-17
JP2010189399A (ja) 2010-09-02
ATE529440T1 (de) 2011-11-15
EP2000478B1 (de) 2011-10-19
US20060172947A1 (en) 2006-08-03
JP2004307454A (ja) 2004-11-04
US7678884B2 (en) 2010-03-16
EP1602665B1 (de) 2010-04-28
WO2004074319A1 (ja) 2004-09-02

Similar Documents

Publication Publication Date Title
BR0111718A (pt) Peptìdeos quimicamente modificados, composições e métodos de produção e uso
CL2003001743A1 (es) Compuestos derivados de leucinamida, inhibidores de la cisteina proteasa; composicion farmaceutica; procedimiento de preparacion de la composicion farmaceutica; y su uso en el tratamiento de la osteoporosis, enfermedad de paget's, peridontal, perdida
ATE196650T1 (de) Stabile bakterizide proteine, welche die permeabilität erhöhen und pharmazeutische zusammensetzungen, diese enthaltend
DE60128916D1 (de) Neues, physiologisch aktives peptid und dessen verwendung
ATE496060T1 (de) Proteinartige verbindungen und anwendungen davon
IL150223A (en) Lipopeptides and pharmaceuticals containing them
ATE494904T1 (de) Verbindungen und verfahren zur erhöhung der neurogenese
DE60327786D1 (de) Kdr-peptide und diese enthaltende impfstoffe
ATE430165T1 (de) Peptide mit integrinbindungsmotiv und behandlungsmethoden für muskelkrankheiten
UA91820C2 (ru) Терапевтическое применение вариантов хемокинов
ATE427320T1 (de) Behandlung von infektionen verursacht von mikroorganismen
WO2004067027A3 (en) Osteogenic composition
DE602004019528D1 (de) Usammensetzungen zur behandlung rekurrenten aphthen in der mundhöhle
EP1940872A4 (de) Peptide, die bei der linderung von hautleiden oder der behandlung von periodentalkrankheiten wirkung zeigen
DE602004026840D1 (de) Physiologisch aktive peptide und medikamente, die diese enthalten
AU2001290480A1 (en) Cyclized benzamide neurokinin antagonists for use in therapy
ATE193305T1 (de) Osteogene wachstums-oligopeptide und diese enthaltende pharmazeutische zusammensetzungen
DE69131355D1 (de) Die knochenresorption hemmende verbindungen und zusammensetzungen
RU2002135669A (ru) Олигопептиды
DE69333351T2 (de) Rekombinante lipase aus hundemagen und pharmazeutische zusammensetzungen
ATE353912T1 (de) Peptizusammensetzung für die mundhöhle
DE60329115D1 (de) Tumorantigenprotein und dessen verwendung
ATE371737T1 (de) Proteaseresistente flint-analoge
MXPA04006457A (es) Alcanosulfonamidas novedosas como antagonistas de endotelina.
NO20052525L (no) Spleisevariant av humant hypofyseveksthormon

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties